Transgene SA (TRGNF) Discusses TG4050 Phase I Immunological Data in Head and Neck Cancer from SITC Presentation Transcript

PresentationI'd now like to turn the call over to Lucie Larguier. Please go ahead, Lucie.Good morning, and welcome to the Transgene conference call. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Transgene website following the event.Lucie LarguierVP & Chief Financial Officer Thank you, Tara, and hello, everyone. Thanks for joining us on today's call, and we will discuss our new TG4050 Phase I immunological data. Today, you will have the opport ...